查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1429644

2024 年智慧胰岛素笔全球市场报告

Smart Insulin Pens Global Market Report 2024
出版日期: 按订单生产 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

智慧胰岛素笔市场规模预计在未来几年将大幅成长。预计到 2028 年将以 6.4% 的复合年增长率 (CAGR) 增长至 1.3 亿美元。预测期内的预期成长可能与疾病负担增加、政府措施和技术改进有关。预测期内预计的主要趋势包括与科技公司的合作、智慧胰岛素输送设备的出现、新型胰岛素输送的进步、物联网的整合以及併购的增加。

与管瓶和注射器相比，胰岛素笔可以达到精确的胰岛素剂量。在儿童在校期间需要胰岛素或视力受损的糖尿病患者等场景中，胰岛素笔可以让您在剂量刻度盘上预设准确的剂量，确保注射时的准确剂量。适合儿童使用的胰岛素笔，例如 Novo Nordisk 的 Echo Plus，允许半单位剂量最多 30 个单位。其他选项，例如礼来公司的 HumaPen Luxura HD，允许以半单位增量进行胰岛素剂量，诺和诺德的 NovoPen Junior 提供高度准确的胰岛素剂量，也可以以半单位增量进行微调。智慧胰岛素笔提供的剂量调整和剂量准确性可以防止剂量过量和剂量不足，从而促进智慧胰岛素笔需求的预期成长并推动市场成长。

智慧胰岛素笔市场的预期成长是由全球糖尿病人口不断增加所推动的。该族群由被诊断患有糖尿病的人组成，糖尿病是一种以血糖值升高为特征的慢性疾病。智慧胰岛素笔透过提供准确的胰岛素剂量追踪、提醒和资料整合来增强糖尿病管理，从而提高糖尿病患者的治疗依从性和整体血糖控制。截至 2021 年 12 月，国际糖尿病联盟报告称，全球有 5.37 亿成年人（20-79 岁）患有糖尿病。据预测，到2030年这数字将增加至6.43亿，到2045年总合将达到7.83亿。因此，全球糖尿病人口的增加是智慧胰岛素笔市场成长的关键驱动力。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球市场驱动因素与限制因素
    • 市场驱动因素
    • 市场限制因素
  • 2018-2023 年全球市场规模表现与成长
  • 全球市场规模预测与成长，2023-2028、2033

第六章市场区隔

  • 全球智慧胰岛素笔市场，按类型细分、实际和预测，2018-2023、2023-2028、2033
  • 第一代笔
  • 第二代笔（相容于蓝牙，USB 连线）
  • 全球智慧胰岛素笔市场，按可用性、实际和预测细分，2018-2023、2023-2028、2033
  • 预填充
  • 可重复使用的
  • 全球智慧胰岛素笔市场，按应用细分、实际和预测，2018-2023、2023-2028、2033
  • 1型糖尿病
  • 2型糖尿病
  • 全球智慧胰岛素笔市场，按最终用户细分，实际和预测，2018-2023、2023-2028、2033
  • 医院和诊所
  • 门诊手术中心
  • 居家照护环境

第 7 章 区域与国家分析

  • 全球智慧胰岛素笔市场、地区、绩效与预测，2018-2023、2023-2028、2033
  • 全球智慧胰岛素笔市场，按国家、实际和预测，2018-2023、2023-2028、2033

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争形势及公司概况

  • 智慧胰岛素笔市场竞争形势
  • 智慧胰岛素笔市场公司概况
    • Companion Medical
    • Novo Nordisk A/S
    • F. Hoffmann-La Roche AG
    • Emperra GmbH E-Health Technologies
    • Diamesco Co. Ltd.

第31章 其他大型创新公司

  • Digital Medics Pvt Ltd.
  • Bigfoot Biomedical
  • Diabnext
  • Insulet Corporation
  • Jiangsu Delfu Medical Device Co. Ltd.
  • Sanofi India
  • Becton Dickinson
  • Roche
  • Biocon Ltd
  • Mehar healthcare
  • Johnson &Johnson
  • GE Healthcare
  • Covidien Healthcare
  • Philips Healthcare India
  • Shandong WeiGao Group Medical Polymer Company Limited

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章 未来前景与可能性分析

第36章附录

简介目录
Product Code: r14615

Smart insulin pens refer to insulin delivery devices designed to monitor and record dosage information, including volume, time, and type. Additionally, these devices may offer functionalities such as generating reports for sharing with healthcare professionals.

Two primary types of smart insulin pens exist first-generation pens and second-generation pens (equipped with Bluetooth or USB connectivity). Second-generation smart insulin pens incorporate Bluetooth or USB features to facilitate closer monitoring. These pens come in either prefilled or reusable forms and are utilized for the treatment of both type 1 diabetes and type 2 diabetes. Smart insulin pens find application across various end-users, including hospitals and clinics, ambulatory surgical centers, as well as home care settings.

The smart insulin pens market research report is one of a series of new reports from The Business Research Company that provides smart insulin pens market statistics, including smart insulin pens industry global market size, regional shares, competitors with a smart insulin pens market share, detailed smart insulin pens market segments, market trends and opportunities, and any further data you may need to thrive in the smart insulin pens industry. This smart insulin pens market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The smart insulin pens market size has grown strongly in recent years. It will grow from $0.1 billion in 2023 to $0.1 billion in 2024 at a compound annual growth rate (CAGR) of 6.0%. The historical period's growth can be ascribed to a rise in the prevalence of diabetes, robust economic expansion in emerging markets, an increased geriatric population, elevated healthcare expenditure, and reforms in public health insurance.

The smart insulin pens market size is expected to see strong growth in the next few years. It will grow to $0.13 billion in 2028 at a compound annual growth rate (CAGR) of 6.4%. The anticipated growth in the forecast period can be linked to an increase in the disease burden, government initiatives, and technological enhancements. Major trends expected in the forecast period involve collaborations with technology companies, the emergence of smart insulin delivery devices, advancements in new types of insulin delivery, the integration of the Internet of Things, and a rise in mergers and acquisitions.

Achieving an accurate dose of insulin is more feasible with an insulin pen compared to a vial or syringe. For scenarios such as children requiring insulin during school hours and visually impaired diabetic patients, the insulin pen allows for pre-setting an accurate dose over the dosage dial, ensuring precise delivery at the time of injection. Pediatric-friendly insulin pens such as Novo Nordisk's Echo Plus enable half-unit dosing, with a maximum of 30 units. Other options such as Lilly's HumaPen Luxura HD allow insulin delivery in half-unit increments, and Novo Nordisk's NovoPen Junior offers highly accurate insulin doses, finely adjusting even in half-unit increments. The precision in dose adjustments and delivery offered by smart insulin pens can prevent both over-dosing and under-dosing, contributing to the expected increase in demand for smart insulin pens and driving market growth.

The anticipated growth of the smart insulin pen market is propelled by the increasing global diabetic population. This population comprises individuals diagnosed with diabetes, a chronic medical condition characterized by elevated blood glucose levels. Smart insulin pens enhance diabetes management by providing precise insulin dosage tracking, reminders, and data integration, thereby improving treatment adherence and overall glycemic control for individuals with diabetes. As of December 2021, the International Diabetes Federation reported that diabetes affected 537 million adults (20-79 years old) globally. Projections indicate that this number will rise to 643 million by 2030 and reach a total of 783 million by 2045. Consequently, the increasing global diabetic population is a key driver for the growth of the smart insulin pen market.

The next generation of smart insulin pens extends beyond simple memory storage capabilities. These advanced devices not only calculate personalized doses but also continuously track glucose levels and integrate with smartphone apps to visualize data. An example of such innovation is the Mallya smart insulin pen device, a collaboration between Biocorp and Roche Diabetes Care France, launched in France in April 2021. The Mallya device is designed to enhance the daily routines of diabetes patients by collecting and storing crucial treatment data, including insulin units, injection dates, and times. The collected data is seamlessly transmitted to a dedicated mobile app, providing both patients and healthcare professionals with convenient access for real-time monitoring and management.

Major companies in the smart insulin pens market are strategically focusing on introducing user-friendly insulin pens, such as the NovoPen 6 and the NovoPen Echo Plus, to optimize revenue in the market. These self-injection pens automatically record insulin dosing information for each injection. For instance, in March 2022, Novo Nordisk A/S, a Denmark-based pharmaceutical company, launched the first smart insulin pens-NovoPen 6 and NovoPen Echo Plus. These pens record details such as the timing and quantity of insulin administered, uploading the data to an app via near-field communication (NFC). The pens facilitate the transfer of insulin dosing information to a patient's preferred diabetes app, allowing data sharing with healthcare providers. They are compatible with smartphones, tablets, personal computers, blood glucose monitors, or other NFC-supported devices.

In October 2023, Novo Nordisk A/S acquired Biocorp, a France-based medical device company specializing in the development and manufacturing of drug-delivery systems and medical devices, for $164.5 million. This acquisition is expected to enable Novo Nordisk to further invest in Biocorp's device development and expedite its ambitions within devices and delivery solutions.

Major companies operating in the smart insulin pens market report are Companion Medical, Novo Nordisk A/S, F. Hoffmann-La Roche AG, Emperra GmbH E-Health Technologies, Diamesco Co. Ltd., Digital Medics Pvt Ltd., Bigfoot Biomedical, Diabnext, Insulet Corporation, Jiangsu Delfu Medical Device Co. Ltd., Sanofi India, Becton Dickinson, Roche, Biocon Ltd., Mehar healthcare, Johnson & Johnson, GE Healthcare, Covidien Healthcare, Philips Healthcare India, Shandong WeiGao Group Medical Polymer Company Limited, Yuwell medical equipment & supply Co, Terumo, NIPRO, Olympus Medical Systems, Hitachi Medico, Nihon Koden, Fukuda Denshi, Medtronic, Ypsomed Holding AG, Berlin-Chemie AG, Patients Pending Ltd., Dexcom, Ok biotech, Insujet, Eli Lilly., Abbott Laboratories, Acon Laboratories, Tandem Diabetes Care, Inc.

North America was the largest region in the smart insulin pens market in 2023. Western Europe was the second largest region in the global smart insulin pens market share. The regions covered in the smart insulin pens market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the smart insulin pens market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The smart insulins pens market consists of sales of instruments such as first-generation pens and second-generation pens (Bluetooth enabled, USB connected). Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Smart Insulin Pens Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on smart insulin pens market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for smart insulin pens? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The smart insulin pens market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type: First Generation Pens; Second Generation Pens
  • 2) By Usability: Prefilled; Reusable
  • 3) By Application: Type 1 Diabetes; Type 2 Diabetes
  • 4) By End User: Hospitals & Clinics; Ambulatory Surgical Centers; Home Care Settings
  • Companies Mentioned: Companion Medical; Novo Nordisk A/S; F. Hoffmann-La Roche AG; Emperra GmbH E-Health Technologies; Diamesco Co. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Smart Insulin Pens Market Characteristics

3. Smart Insulin Pens Market Trends And Strategies

4. Smart Insulin Pens Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Smart Insulin Pens Market Size and Growth

  • 5.1. Global Smart Insulin Pens Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Smart Insulin Pens Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Smart Insulin Pens Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Smart Insulin Pens Market Segmentation

  • 6.1. Global Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • First Generation Pens
  • Second Generation Pens (Bluetooth Enabled, USB Connected)
  • 6.2. Global Smart Insulin Pens Market, Segmentation By Usability, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Prefilled
  • Reusable
  • 6.3. Global Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Type 1 Diabetes
  • Type 2 Diabetes
  • 6.4. Global Smart Insulin Pens Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Home Care Settings

7. Smart Insulin Pens Market Regional And Country Analysis

  • 7.1. Global Smart Insulin Pens Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Smart Insulin Pens Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Smart Insulin Pens Market

  • 8.1. Asia-Pacific Smart Insulin Pens Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Smart Insulin Pens Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Smart Insulin Pens Market

  • 9.1. China Smart Insulin Pens Market Overview
  • 9.2. China Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Smart Insulin Pens Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Smart Insulin Pens Market

  • 10.1. India Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Smart Insulin Pens Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Smart Insulin Pens Market

  • 11.1. Japan Smart Insulin Pens Market Overview
  • 11.2. Japan Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Smart Insulin Pens Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Smart Insulin Pens Market

  • 12.1. Australia Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Smart Insulin Pens Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Smart Insulin Pens Market

  • 13.1. Indonesia Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Smart Insulin Pens Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Smart Insulin Pens Market

  • 14.1. South Korea Smart Insulin Pens Market Overview
  • 14.2. South Korea Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Smart Insulin Pens Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Smart Insulin Pens Market

  • 15.1. Western Europe Smart Insulin Pens Market Overview
  • 15.2. Western Europe Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Smart Insulin Pens Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Smart Insulin Pens Market

  • 16.1. UK Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Smart Insulin Pens Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Smart Insulin Pens Market

  • 17.1. Germany Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Smart Insulin Pens Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Smart Insulin Pens Market

  • 18.1. France Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Smart Insulin Pens Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Smart Insulin Pens Market

  • 19.1. Italy Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Smart Insulin Pens Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Smart Insulin Pens Market

  • 20.1. Spain Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Smart Insulin Pens Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Smart Insulin Pens Market

  • 21.1. Eastern Europe Smart Insulin Pens Market Overview
  • 21.2. Eastern Europe Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Smart Insulin Pens Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Smart Insulin Pens Market

  • 22.1. Russia Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Smart Insulin Pens Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Smart Insulin Pens Market

  • 23.1. North America Smart Insulin Pens Market Overview
  • 23.2. North America Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Smart Insulin Pens Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Smart Insulin Pens Market

  • 24.1. USA Smart Insulin Pens Market Overview
  • 24.2. USA Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Smart Insulin Pens Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Smart Insulin Pens Market

  • 25.1. Canada Smart Insulin Pens Market Overview
  • 25.2. Canada Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Smart Insulin Pens Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Smart Insulin Pens Market

  • 26.1. South America Smart Insulin Pens Market Overview
  • 26.2. South America Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Smart Insulin Pens Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Smart Insulin Pens Market

  • 27.1. Brazil Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Smart Insulin Pens Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Smart Insulin Pens Market

  • 28.1. Middle East Smart Insulin Pens Market Overview
  • 28.2. Middle East Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Smart Insulin Pens Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Smart Insulin Pens Market

  • 29.1. Africa Smart Insulin Pens Market Overview
  • 29.2. Africa Smart Insulin Pens Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Smart Insulin Pens Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Smart Insulin Pens Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Smart Insulin Pens Market Competitive Landscape And Company Profiles

  • 30.1. Smart Insulin Pens Market Competitive Landscape
  • 30.2. Smart Insulin Pens Market Company Profiles
    • 30.2.1. Companion Medical
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Novo Nordisk A/S
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. F. Hoffmann-La Roche AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Emperra GmbH E-Health Technologies
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Diamesco Co. Ltd.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Smart Insulin Pens Market Other Major And Innovative Companies

  • 31.1. Digital Medics Pvt Ltd.
  • 31.2. Bigfoot Biomedical
  • 31.3. Diabnext
  • 31.4. Insulet Corporation
  • 31.5. Jiangsu Delfu Medical Device Co. Ltd.
  • 31.6. Sanofi India
  • 31.7. Becton Dickinson
  • 31.8. Roche
  • 31.9. Biocon Ltd
  • 31.10. Mehar healthcare
  • 31.11. Johnson & Johnson
  • 31.12. GE Healthcare
  • 31.13. Covidien Healthcare
  • 31.14. Philips Healthcare India
  • 31.15. Shandong WeiGao Group Medical Polymer Company Limited

32. Global Smart Insulin Pens Market Competitive Benchmarking

33. Global Smart Insulin Pens Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Smart Insulin Pens Market

35. Smart Insulin Pens Market Future Outlook and Potential Analysis

  • 35.1 Smart Insulin Pens Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Smart Insulin Pens Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Smart Insulin Pens Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer